Dysphagia in dermatomyositis secondary to bladder cancer: rapid response to combined immunoglobulin and methylprednisolone.
Hafejee
A
A
Coulson
I H
IH
D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D002295:Carcinoma, Transitional Cell / Q000150:complications / Q000556:secondary; D003680:Deglutition Disorders / Q000188:drug therapy*; D003882:Dermatomyositis / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage*; D001749:Urinary Bladder Neoplasms / Q000150:complications
D000893:Anti-Inflammatory Agents; D016756:Immunoglobulins, Intravenous; D008775:Methylprednisolone